Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX157 in Major Depressive Disorder
NCT00739908Phase 2Completed
- Sponsor
- CeNeRx BioPharma
- Start
- Sep 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CX157 in major depressive disorder (MDD), sponsored by CeNeRx BioPharma. Started Sep 2008; status: completed.
02
Drugs
CX157
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00739908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739908.